L&C BIO · 연결재무제표기준영업(잠정)실적(공정공시)
Preliminary consolidated operating results (Fair Disclosure)
| Results Period | |||
| Current Period Results | 2026-07-01 | ~ | 2026-09-30 |
| Prior Period Results | 2026-04-01 | ~ | 2026-06-30 |
| Prior-Year Same Period Results | 2025-07-01 | ~ | 2025-09-30 |
| Current Period Cumulative Results | 2026-01-01 | ~ | 2026-09-30 |
| Prior-Year Same Period Cumulative Results | 2025-01-01 | ~ | 2025-09-30 |
| ※ This information is preliminary, not final, and may differ from final figures. | ||||||||
| 1. Consolidated results | ||||||||
| Category (Unit: KRW m, %) | Current Period Results | Prior Period Results | vs. Prior Period | Prior-Year Same Period Results | YoY | |||
| ('26.3Q) | ('26.2Q) | Change (%) | Profit/loss turnaround | ('25.3Q) | Change (%) | Profit/loss turnaround | ||
| Revenue | Current Results | 38,447 | 38,785 | -0.9 | - | 22,556 | 70.4 | - |
| Cumulative Results | 107,527 | - | - | - | 60,808 | 76.8 | - | |
| Operating Income | Current Results | 9,839 | 8,580 | 14.7 | - | 2,896 | 239.8 | - |
| Cumulative Results | 24,417 | - | - | - | 2,461 | 892.1 | - | |
| Income from continuing operations before income tax | Current Results | 7,912 | -7,116 | - | Turned to Profit | -51,331 | - | Turned to Profit |
| Cumulative Results | 3,808 | - | - | - | -65,987 | - | Turned to Profit | |
| Net Income | Current Results | 4,898 | -28,123 | - | Turned to Profit | -51,338 | - | Turned to Profit |
| Cumulative Results | -20,499 | - | - | - | -66,257 | 69.1 | - | |
| Net income attributable to owners of the parent | Current Results | 4,704 | -27,999 | - | Turned to Profit | -51,460 | - | Turned to Profit |
| Cumulative Results | -20,692 | - | - | - | -65,619 | 68.5 | - | |
| - | - | - | - | - | - | - | - | |
| 2. Information Provided | Information Provider | (주)엘앤씨바이오 경영관리팀 | ||||||
| Information Recipient | 국내외 투자자,애널리스트 및 언론 | |||||||
| Information release date (scheduled) | 2026.11.09(월) | |||||||
| Information release time (scheduled) | Ad hoc provision after fair disclosure | |||||||
| Event Name (Venue) | - | |||||||
| 3. Contact | Chief Disclosure Officer (Name) | 이재호 대표이사 | ||||||
| Chief Disclosure Officer (Phone) | 070-7733-8358 | |||||||
| Disclosure Officer (Name) | 이종찬 과장 | |||||||
| Disclosure Officer (Phone) | 070-7733-8358 | |||||||
| Department Name | 경영관리팀 | |||||||
| Department (Phone) | 070-7733-8358 | |||||||
| 4. Other Matters Relevant to Investment Decisions | - 상기 실적은 한국채택국제회계기준(K-IFRS)에 따라 작성된 연결재무제표(잠정) 기준입니다. - 상기 실적은 외부감사인의 검토를 받지 아니한 자체 결산자료로서, 향후 외부감사인의 감사 및 검토결과에 따라 변동될 수 있습니다. | |||||||
| ※ Related Disclosures | - | |||||||